WallStreetZenWallStreetZen

NASDAQ: THAR
Tharimmune Inc Stock Ownership - Who owns Tharimmune?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Tharimmune Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Randy MilbyCEO2024-12-194,600$2.12
$9.75kBuy
Sireesh AppajosyulaChief Operating Officer2024-11-135,000$2.02
$10.10kBuy
Sireesh AppajosyulaChief Operating Officer2024-10-085,000$1.93
$9.65kBuy
Sireesh AppajosyulaChief Operating Officer2024-10-085,000$1.93
$9.65kBuy
Randy MilbyCEO2024-10-08646$2.09
$1.35kBuy
Randy MilbyCEO2024-10-081,500$2.09
$3.13kBuy
Randy MilbyCEO2024-10-08354$2.10
$743.40Buy
Sireesh AppajosyulaChief Operating Officer2024-10-085,000$1.93
$9.65kBuy

1 of 1

THAR insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when THAR insiders and whales buy or sell their stock.

THAR Shareholders

What type of owners hold Tharimmune Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Highpoint Pharmaceuticals LLC46.10%972,222$1.50MInsider
Kufe LLC38.43%810,395$1.25MInsider
Surender Kharbanda34.20%721,240$1.11MInsider
Varinder Kaur30.97%653,059$1.01MInsider
Sandeep Laumas30.16%636,008$979.45kInsider
Leonard L. Mazur5.87%123,733$190.55kInsider
Ubs Group Ag2.25%47,465$73.10kInstitution
Curi Rmb Capital LLC1.12%23,620$36.37kInstitution
Virtu Financial LLC1.01%21,371$32.91kInstitution
Citadel Advisors LLC0.86%18,129$27.92kInstitution

1 of 2

THAR vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
THAR3.64%96.36%Net Buying
EYEN24.03%75.97%Net Buying
ENVB43.67%38.75%
LIXT5.13%94.87%
PCSA0.83%34.14%Net BuyingNet Selling
View Top Biotech Stocks

Tharimmune Stock Ownership FAQ

Who owns Tharimmune?

Tharimmune (NASDAQ: THAR) is owned by 7.07% institutional shareholders, 187.08% Tharimmune insiders, and 0.00% retail investors. Highpoint Pharmaceuticals LLC is the largest individual Tharimmune shareholder, owning 972,222.00 shares representing 46.10% of the company. Highpoint Pharmaceuticals LLC's Tharimmune shares are currently valued at $1.45M.

If you're new to stock investing, here's how to buy Tharimmune stock.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.